Uric acid and evolution

Role of the urate transporterSLC2A9gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets

(2009) Jade E. Hollis-Moffatt et al.   ARTHRITIS AND RHEUMATISM

Recent insights into the pathogenesis of hyperuricaemia and gout

(2009) P. L. Riches et al.   HUMAN MOLECULAR GENETICS

Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?

(2009) D. Keizman et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Gout

(2009) Pascal Richette et al.   LANCET

The modern management of gout

(2009) Tom G. Rider et al.   RHEUMATOLOGY

Treating to target: a strategy to cure gout

(2009) F. Perez-Ruiz   RHEUMATOLOGY

New insights into the epidemiology of gout

(2009) M. Doherty   RHEUMATOLOGY

Febuxostat: a new treatment for hyperuricaemia in gout

(2009) N. L. Edwards   RHEUMATOLOGY

Gout: an independent risk factor for all-cause and cardiovascular mortality

(2009) Chang-Fu Kuo et al.   RHEUMATOLOGY

Diet, Urate, and Parkinson's Disease Risk in Men

(2008) X. Gao et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study

(2008) Adriana G. Ioachimescu et al.   ARTHRITIS AND RHEUMATISM

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

(2008) Veronique Vitart et al.   NATURE GENETICS

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE